Cerebral small vessel disease (SVD) is an umbrella term covering a variety of abnormalities related to small blood vessels in the brain. Because most brain tissue appears white on MRIs, these abnormalities were historically referred to as “white matter changes” or …

Cerebral Small Vessel Disease (CSVD) is an umbrella term for a range of conditions caused by damage to small blood vessels in the brain. Typically, CSVD results from the narrowing or blockage of these vessels due to inflammation, hardening of the arteries, plaque buildup, or the thickening of the vessel walls.

2024年9月30日 · Explore small vessel disease in the brain, including causes, symptoms, diagnosis, and treatment options. Learn about risk factors and long-term prognosis.

2023年5月9日 · Cerebral Small Vessel Disease, also referred to as small vessel ischemic disease, is a common condition that affects the small blood vessels in the brain. This condition can lead to significant health problems, including stroke and dementia.

What is Cerebral Small Vessel Disease (CSVD)? Cerebral small vessel disease includes various conditions in which small blood vessels in the brain are damaged, often causing stroke. CSVD causes impaired blood flow to the brain, or ischemic disease, which can be associated with dementia if it progresses. It is most common in older adults.

Cerebral small vessel disease (CSVD) is the most common, chronic and progressive vascular disease. The changes affect arterioles, capillaries and small veins supplying the white matter and deep structures of the brain.

2024年5月31日 · Small vessel disease is the most common form of cerebrovascular disease, that is, blood vessel disease of the brain. Damaged small blood vessels in the brain can cause white matter lesions and other signs that are seen on brain scans.

2024年3月28日 · Cerebral Small Vessel Disease is Associated with Prehospital Delay in Acute Ischemic Stroke, Journal of Atherosclerosis and Thrombosis, 32, 2, (198-209), (2025). https://doi.org/10.5551/jat.64968

2014年2月6日 · Small vessel disease (SVD) of the brain accounts for ≈25% to 30% of strokes and is a leading cause of age-related and hypertension-related cognitive decline and disability. 1 Despite its impact on the brain, there are currently no specific treatments for SVD, and therapeutic options for secondary prevention are particularly limited compared ...

There are four main clinical manifestations of CSVD: stroke, cognitive impairment, recurrent lacunar infarction, and white matter lesions (WMLs).